Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Regenxbio (RGNX) Non-Current Receivables (2018 - 2025)

Historic Non-Current Receivables for Regenxbio (RGNX) over the last 8 years, with Q3 2025 value amounting to $2.8 million.

  • Regenxbio's Non-Current Receivables rose 58440.59% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 58440.59%. This contributed to the annual value of $474000.0 for FY2024, which is 3238.23% down from last year.
  • Regenxbio's Non-Current Receivables amounted to $2.8 million in Q3 2025, which was up 58440.59% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Regenxbio's Non-Current Receivables peaked at $6.0 million during Q2 2022, and registered a low of $404000.0 during Q3 2024.
  • Over the past 5 years, Regenxbio's median Non-Current Receivables value was $1.6 million (recorded in 2025), while the average stood at $2.4 million.
  • In the last 5 years, Regenxbio's Non-Current Receivables plummeted by 9097.0% in 2024 and then soared by 58440.59% in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Non-Current Receivables stood at $3.8 million in 2021, then crashed by 59.98% to $1.5 million in 2022, then plummeted by 53.39% to $701000.0 in 2023, then crashed by 32.38% to $474000.0 in 2024, then soared by 483.33% to $2.8 million in 2025.
  • Its Non-Current Receivables stands at $2.8 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.2 million for Q1 2025.